Haichen Pharmaceutical announced that progress has been made in the transfer of 20% of Nanjing Yuanchen New Energy Technology Co., Ltd's shares held by Cao Yuping, the controlling shareholder and actual controller of the company: the company has paid 4 million yuan of equity transfers in full, and Nanjing Yuanchen has completed the registration of commercial changes and issued a business license. After the change, the company held 20% of Nanjing Yuanchen's shares and Cao Yuping held 40% of the shares. This transaction is a related transaction. It does not constitute a major asset restructuring, and there is no need to submit it to the shareholders' meeting for consideration.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.